EBC

Registration is now open for the two-day Brain Innovation Days event, to be held physically in Brussels, Belgium, on 12-13 October.

EPICLUSTER will hold its 3rd activity on Accelerating Patient Involvement in European Epilepsy Research on 6 October from 9:30 to 13:00 CET

The Brain Innovation Days team is very pleased to announce that registration is now open for the third Brain Innovation Days event, to be held virtually on 27 April 2021 at 12:30 – 14:00 CET.

The European Brain Council (EBC) announced the release of its Policy Roadmap ‘Brain Health in Europe: Fostering Innovation, Improving Outcomes’ on the occasion of Brain Awareness Week 2021.

EBC launches statement on the impact of COVID-19 on brain health

The European Brain Council (EBC) is very pleased to announce the launch of updated disease fact sheets, providing a quick overview of key facts, history, known causes, diagnosis, symptoms and treatment of brain disorders – neurological and mental alike.

The call for applications for the Brain Innovation Days Pitch Competition, “My start-up in 180 seconds”, is currently open!

The European Brain Council and beLean.net are happy to announce the digital launch of the Brain Innovation Days, to be held on 13 October 2020 at 12:30-14:30.

The EBC releases its 2019 Annual Report

The European Brain Research Area project – EBRA – was created as a catalyzing platform for brain research stakeholders (researchers, clinicians, patients, governments, funders and public institutions) to streamline and better coordinate brain research across Europe.

The European Brain Council (EBC) has launched a new video series, “Science and Society”, to raise awareness of brain disorders and for those living with these conditions.

RETHINKING MS in Europe, offering tangible policy changes to improve the lives of people living with MS across Europe, went live during Brain Awareness Week On the occasion of the Brain Awareness Week (16-22 March 2020), the European Brain Council… Continue Reading

Meeting of WHO with EFNA, EAN and EBC to discuss brain health Report Objectives: Platform for all participants to present their ongoing work and discuss potential collaboration in the area of brain health Participants: European Academy of Neurology (EAN): Raad… Continue Reading

The first public event of the EBRA-project was held on 5 December 2019 in Brussels, Belgium.

The AD Detect and Prevent project, which is funded through Horizon 2020 and led by the Danish digital therapeutics company Brain+, aims to develop a robust digital tool for improving the early detection of Alzheimer’s disease (AD). This integrated tool aims to first detect subtle cognitive signs associated with Alzheimer’s disease (before the possible emergence of clear symptoms) and to subsequently provide personalized intervention programmes that address risk factors connected to Alzheimer’s dementia.